bupropion has been researched along with reboxetine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almási, J; Rihmer, Z | 1 |
| Blackburn-Munro, G; Nielsen, AN; Pedersen, LH | 1 |
| Millan, MJ | 1 |
| Gannon, RL; Millan, MJ | 1 |
| Choong, E; Eap, CB; Guillarme, D; Haldemann, S; Kottelat, A; Rudaz, S; Veuthey, JL | 1 |
| Blamire, AM; Lowe, AS; Sekar, S; Shoaib, M; Steckler, T; Van Audekerke, J; Van der Linden, A; Vanhoutte, G; Verhoye, M | 1 |
| Młyniec, K; Nowak, G | 2 |
| Cadeddu, R; Carboni, E; Ibba, M; Sadile, A | 1 |
| Krakowska, A; Mlyniec, K; Nowak, G; Opoka, W; Ostachowicz, B; Reczynski, W | 1 |
| Filipek, B; Olczyk, A; Pytka, K; Rapacz, A; Sapa, J; Waszkielewicz, A; Zygmunt, M | 1 |
| Rahman, S; Roni, MA | 1 |
| Buoli, M; Cahn, W; Serati, M | 1 |
3 review(s) available for bupropion and reboxetine
| Article | Year |
|---|---|
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Dopamine; Dopamine Uptake Inhibitors; Drug Delivery Systems; Drug Design; Drug Therapy, Combination; Humans; Morpholines; Nerve Net; Neurons; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2006 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
10 other study(ies) available for bupropion and reboxetine
| Article | Year |
|---|---|
Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain.
Topics: Amines; Analgesics; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Constriction; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Male; Morpholines; Motor Activity; Neurotransmitter Uptake Inhibitors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reboxetine; Rotarod Performance Test; Spinal Cord Injuries; Vesicular Monoamine Transport Proteins | 2005 |
Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
Topics: Adrenergic Uptake Inhibitors; Animals; Bupropion; Circadian Rhythm; Cricetinae; Cyclohexanols; Dopamine Uptake Inhibitors; Light; Male; Mesocricetus; Morpholines; Motor Activity; Reboxetine; Running; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.
Topics: Antidepressive Agents; Bupropion; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Humans; Moclobemide; Morpholines; Reboxetine; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Trazodone | 2011 |
Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.
Topics: Animals; Antidepressive Agents; Brain; Brain Mapping; Bupropion; Cerebrovascular Circulation; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Magnetic Resonance Imaging; Male; Morpholines; Oxygen; Rats; Rats, Inbred Strains; Reboxetine | 2011 |
GPR39 up-regulation after selective antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Citalopram; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptors, G-Protein-Coupled; Up-Regulation; Zinc | 2013 |
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy?
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Male; Morpholines; Norepinephrine; Rats, Sprague-Dawley; Reboxetine; Septal Nuclei; Time Factors | 2014 |
Chronic but not acute antidepresant treatment alters serum zinc/copper ratio under pathological/zinc-deficient conditions in mice.
Topics: Animals; Antidepressive Agents; Bupropion; Citalopram; Copper; Depression; Disease Models, Animal; Imipramine; Male; Mice; Morpholines; Reboxetine; Sodium Chloride; Zinc | 2014 |
Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system.
Topics: Animals; Antidepressive Agents; Bupropion; Depressive Disorder; Fenclonine; Fluoxetine; Male; Mice; Morpholines; Motor Activity; Piperazines; Postural Balance; Reboxetine; Serotonin; Serotonin Agents; Swimming; Xanthones | 2015 |
Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depression; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Immobility Response, Tonic; Lobeline; Male; Mice; Morpholines; Reboxetine | 2015 |
Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Bupropion; Citalopram; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Drug Administration Schedule; Frontal Lobe; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptor, trkB; Receptors, G-Protein-Coupled; Signal Transduction; Up-Regulation; Zinc | 2015 |